User menu

Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial

Bibliographic reference de Jager, J. ; Kooy, A. ; Schalkwijk, C. ; van der Kolk, J. ; Lehert, Philippe ; et. al. Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. In: Journal of Internal Medicine : from genes and molecules to patients, Vol. 275, no.1, p. 59-70 (2014)
Permanent URL
  1. Bonow Robert O, Gheorghiade Mihai, The diabetes epidemic: a national and global crisis, 10.1016/j.amjmed.2003.10.014
  2. Ross Russell, Atherosclerosis — An Inflammatory Disease, 10.1056/nejm199901143400207
  3. Jager A., van Hinsbergh V. W. M., Kostense P. J., Emeis J. J., Yudkin J. S., Nijpels G., Dekker J. M., Heine R. J., Bouter L. M., Stehouwer C. D. A., von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects : The Hoorn Study, 10.1161/01.atv.19.12.3071
  4. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), 10.1016/s0140-6736(98)07037-8
  5. Kooy Adriaan, de Jager Jolien, Lehert Philippe, Bets Daniël, Wulffelé Michiel G., Donker Ab J. M., Stehouwer Coen D. A., Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus, 10.1001/archinternmed.2009.20
  6. Mather Kieren J, Verma Subodh, Anderson Todd J, Improved endothelial function with metformin in type 2 diabetes mellitus, 10.1016/s0735-1097(01)01129-9
  7. Nagi D. K., Yudkin J. S., Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groups, 10.2337/diacare.16.4.621
  8. Charles M. A., Morange P., Eschwege E., Andre P., Vague P., Juhan-Vague I., Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity, 10.2337/diacare.21.11.1967
  9. Grant P. J., The Effects of High- and Medium-Dose Metformin Therapy on Cardiovascular Risk Factors in Patients With Type II Diabetes, 10.2337/diacare.19.1.64
  10. Wulffele M. G., Kooy A., Lehert P., Bets D., Ogterop J. C., Borger van der Burg B., Donker A. J.M., Stehouwer C. D.A., Combination of Insulin and Metformin in the Treatment of Type 2 Diabetes, 10.2337/diacare.25.12.2133
  11. Wulffele M. G., Kooy A., Lehert P., Bets D., Donker A. J. M., Stehouwer C. D. A., Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?, 10.1111/j.1464-5491.2005.01554.x
  12. JAGER J., KOOY A., LEHERT Ph., BETS D., WULFFELE M. G., TEERLINK T., SCHEFFER P. G., SCHALKWIJK C. G., DONKER A. J. M., STEHOUWER C. D. A., Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial, 10.1111/j.1365-2796.2004.01420.x
  13. Passing, J Clin Chem Clin Biochem, 21, 709 (1983)
  14. Passing, J Clin Chem Clin Biochem, 22, 431 (1984)
  15. Stehouwer C, Endothelial dysfunction and pathogenesis of diabetic angiopathy, 10.1016/s0008-6363(96)00272-6
  16. Mannucci P. M., von Willebrand Factor : A Marker of Endothelial Damage?, 10.1161/01.atv.18.9.1359
  17. Vapaatalo, Med Sci Monit, 7, 1075 (2001)
  18. Blake G. J., Ridker P. M., Novel Clinical Markers of Vascular Wall Inflammation, 10.1161/hh2101.099270
  19. Ridker Paul M., Hennekens Charles H., Buring Julie E., Rifai Nader, C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women, 10.1056/nejm200003233421202
  20. Brevetti, Thromb Haemost, 85, 63 (2001)
  21. Preacher Kristopher J., Hayes Andrew F., Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models, 10.3758/brm.40.3.879
  22. Brown Roger L., Assessing specific mediational effects in complex theoretical models, 10.1080/10705519709540067
  23. Briggs, Dissert Abst Int, 37, 4755B (2006)
  24. de Jager J., Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study, 10.1161/01.atv.0000215951.36219.a4
  25. Lund S. S, Tarnow L., Stehouwer C. D A, Schalkwijk C. G, Teerlink T., Gram J., Winther K., Frandsen M., Smidt U. M, Pedersen O., Parving H.-H., Vaag A. A, Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes, 10.1530/eje-07-0815
  26. Ryysy L., Yki-Jarvinen H., Improvement of Glycemic Control by 1 Year of Insulin Therapy Leads to a Sustained Decrease in sE-Selectin Concentrations in Type 2 Diabetes, 10.2337/diacare.24.3.549
  27. Diamanti-Kandarakis Evanthia, Paterakis Thomas, Alexandraki Krystallenia, Piperi Christina, Aessopos Athanasios, Katsikis Ilias, Katsilambros Nikolaos, Kreatsas George, Panidis Dimitrios, Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin, 10.1093/humrep/del003
  28. Škrha Jan, Prázný Martin, Hilgertová Jiřina, Kvasnička Jan, Kalousová Marta, Zima Tomáš, Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus, 10.1007/s00228-007-0378-1
  29. Vischer, Thromb Haemost, 80, 1002 (1998)
  30. Amador-Licona Norma, Guı́zar-Mendoza Juan-Manuel, Vargas Enrique, Sánchez-Camargo Guillermo, Zamora-Mata Lilia, The Short-Term Effect of a Switch from Glybenclamide to Metformin on Blood Pressure and Microalbuminuria in Patients with Type 2 Diabetes Mellitus, 10.1016/s0188-4409(00)00241-1
  31. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A., Albuminuria reflects widespread vascular damage : The Steno hypothesis, 10.1007/bf00285287
  32. Hattori Y., Suzuki K., Hattori S., Kasai K., Metformin Inhibits Cytokine-Induced Nuclear Factor  B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells, 10.1161/01.hyp.0000221429.94591.72
  33. Ewart M.-A., Kohlhaas C. F., Salt I. P., Inhibition of Tumor Necrosis Factor  -Stimulated Monocyte Adhesion to Human Aortic Endothelial Cells by AMP-Activated Protein Kinase, 10.1161/atvbaha.108.175919
  34. van Bussel Bas C.T., Henry Ronald M.A., Schalkwijk Casper G., Dekker Jacqueline M., Nijpels Giel, Stehouwer Coen D.A., Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly : the Hoorn Study, 10.1097/hjh.0b013e328350a487
  35. Beisswenger P. J., Howell S. K., Touchette A. D., Lal S., Szwergold B. S., Metformin reduces systemic methylglyoxal levels in type 2 diabetes, 10.2337/diabetes.48.1.198
  36. Ruggiero-Lopez Daniel, Lecomte Marc, Moinet Gérard, Patereau Gérard, Lagarde Michel, Wiernsperger Nicolas, Reaction of metformin with dicarbonyl compounds. possible implication in the inhibition of advanced glycation end product formation, 10.1016/s0006-2952(99)00263-4
  37. Tanaka Yasushi, Uchino Hiroshi, Shimizu Tomoaki, Yoshii Hidenori, Niwa Masataka, Ohmura Chie, Mitsuhashi Naomi, Onuma Tomio, Kawamori Ryuzo, Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats, 10.1016/s0014-2999(99)00342-8
  38. Fujita Hiroki, Fujishima Hiromi, Morii Tsukasa, Koshimura Jun, Narita Takuma, Kakei Masafumi, Ito Seiki, Effect of metformin on adipose tissue resistin expression in db/db mice, 10.1016/s0006-291x(02)02464-6
  39. Fruehwald-Schultes Bernd, Oltmanns Kerstin M., Toschek Barbara, Sopke Stefan, Kern Werner, Born Jan, Fehm Horst L., Peters Achim, Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men, 10.1053/meta.2002.31332
  40. Phillips S. A., Ciaraldi T. P., Kong A. P.S., Bandukwala R., Aroda V., Carter L., Baxi S., Mudaliar S. R., Henry R. R., Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy, 10.2337/diabetes.52.3.667
  41. Bruun J., Pedersen S., Richelsen B., Interleukin-8 Production in Human Adipose Tissue. Inhibitory Effects of Anti-Diabetic Compounds, the Thiazolidinedione Ciglitazone and the Biguanide Metformin, 10.1055/s-2007-978682
  42. Solomon S., Mishra S., Cwik C., Rajanna B., Postlethwaite A., Pioglitazone and Metformin Reverse Insulin Resistance Induced by Tumor Necrosis Factor-Alpha in Liver Cells, 10.1055/s-2007-979059